Federal award
RIDGELINE THERAPEUTICS, INC.
W81XWH1910290
Assistance
Obligated and Ceiling
- Obligated (net)
- $4,192,268.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $4,192,268.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- RIDGELINE THERAPEUTICS, INC. · KM9RHDLMHTN5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 2100 · office W81XWH
- Funding agency
- Department of Defense · sub-agency 2100
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH1910290
- Award type code
- 04
- Actions
- 4 · Jun 19, 2019 to Jun 28, 2022
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 28, 2022 | FY2022 | P00003 | B1 | $0.00 | — |
| Feb 25, 2020 | FY2020 | P00002 | EX | $0.00 | — |
| Oct 23, 2019 | FY2020 | P00001 | EX | $0.00 | — |
| Jun 19, 2019 | FY2019 | 0 | A1 | $4,192,268.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.